Interaction between calcineurin-dependent drugs and the tolerogenic effect induced by anti-LFA-1 monoclonal antibody treatment in a small bowel transplantation model in mice;Role des drogues calcineurine-dependantes sur l'effet immunosuppresseur induit par l'anticorps anti-LFA-1 dans un module de greffe intestinale foetale chez la souris

Chirurgie

Volumn 124, Issue 5, 1999, Pages 503-510

  Cretolle Vastel C ^a,b   Camby, C ^a,b   Cerf Bensussan, N ^b   Cavazzana Calvo, M ^c   Fischer, A ^c   Revillon Y ^a   Sarnacki, S ^a,b  

^a HÔpital Necker Enfants Malades   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Anti LFA 1 monoclonal antibody; Calcineurin dependent drugs; Mice; Small bowel transplantation; Tolerance

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY; MONOCLONAL ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG; ANTI LFA 1 MONOCLONAL ANTIBODY; ANTI-LFA-1 MONOCLONAL ANTIBODY; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MIXTURE; DRUG TOLERABILITY; GRAFT REJECTION; GRAFT SURVIVAL; INTESTINE TRANSPLANTATION; MALE; MOUSE; NONHUMAN; ANIMAL; BIOPSY; C3H MOUSE; C57BL MOUSE; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; FETUS; IMMUNOLOGY; PATHOLOGY; SMALL INTESTINE; TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOPSY; CALCINEURIN; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; TACROLIMUS;

EID: 0033231415     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4001(00)88272-0     Document Type: Article

References (23)

1. Vanderhoof JA. Short bowel syndrome in children and small intestinal transplantation. Pediatr Clin North Am 1996 ; 43 : 533-50.
2. Grant D. Intestinal transplantation : 1997 report of the international registry. Intestinal transplant registry. Transplantation 1999 ; 67 : 1061-4.
3. Grant D. Current results of intestinal transplantation. Lancet 1996 ; 347 : 1801-3.
4. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990 ; 248 : 1349-56.
5. Schwartz RH. Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 1996 ; 184 : 1-8.
6. Cavazzana-Calvo M, Sarnacki S, Haddad E, DeCoene C, Calise D, Yvon E, et al. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Transplantation 1995 ; 11 : 1576-82.
7. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992 ; 255 : 1125-7.
8. Paul LC, Davidoff A, Benediktsson M. The efficacity of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation 1993 ; 55 : 665-7.
9. VanDijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, Ferrara LM. Evidence that anti-LFA-1 in vivo improves engrafment and survival after allogeneic bone marrow transplantation. Transplantation 1990 ; 49 : 882-6.
10. Auber F, Cerf-Bensussan N, Cavazzana-Calvo M, Fauveau V, Brousse N, Fischer A, et al. Prévention du rejet d'allogreffe intestinale par des anticorps antimolécules d'adhésion dans un modèle murin. Chirurgie 1998 ; 123 : 122-30.
11. Fischer A, Friedrich W, Fasth A, Blanche S, LeDeist F, Girault D, et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: A european group for immnudeficiency/ european group for bone marrow transplantation report. Blood 1991 ; 77 : 249-56.
12. Hourmant M, Bedrossian J, Durand D, Lebranchu Y, Renoult E, Caudrelier P, et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996 ; 62 : 1565-70.
13. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996 ; 381 : 434-8.
14. Kato Y, Yamataka A, Yagita H, Okumura K, Fujiwara T, Miyano T. Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies. Ann Surg 1996 ; 223 :94-100.
15. Kato Y, Yamataka A, Yagita H, Bashuda H, Okumura K, Miyano T. Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 anti-LFA-1 antibodies. J Ped Surg 1995 ; 30 : 1093-7.
16. Davignon D, Martz E, Reynolds T, Kürzinger K, Springer TA. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): Mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. J Immunol 1981 ; 127 : 590-5.
17. Nakakura EK, Shorthouse RA, Zheng B, McCabe S, Jardieu PM, Morris RE. Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Transplantation 1996 ; 62 : 547-52.
18. LeMauff B, Hourmant M, Rougier JP, Hirn M, Dantal J, Baatard R, et al. Effects of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation 1991 ; 52 : 291-6.
19. Bashuda H, Seino K, Ra C, Yagita H, Okumura K. Lack of cognate help by CD4+T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/ intercellular adhesion molecule-1-induced cardiac allograft tolerance. Transplantation 1997 ; 63 : 113-8.
20. Isobe M, Suzuki J, Yamazaki S, Sekiguchi M. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. Transplant Proc 1996 ; 28 : 1045-6.
21. Truffa-Bachi P. La Cyclosporine A: Effets sur les Réponses Immunitaires et Aspects Moléculaires. Paris : Institut Pasteur : Cours d'Immunologie approfondie ; 1997-1998.
22. Yamagami S, Isobe M, Yamagami H, Hori J, Tsuru T. Mechanism of concordant corneal xenograft rejection in mice. Transplantation 1997 ; 64 : 42-8.
23. Nakakura EK, McCabe S, Zheng B, Shorthouse RA, Scheiner TM, Blank G, et al. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation 1993 ; 55 : 412-7.